Activity ID
14516Expires
February 17, 2027Format Type
EnduringCME Credit
0.5Fee
$0CME Provider: PeerView Institute for Medical Education
Description of CME Course
Practice Gap: Underdiagnosis of AD in the early stages of the disease (eg, MCI or mild dementia due to AD), with diagnosis often delayed by 2–3 years and up to 90% of patients with MCI remaining undiagnosed or incorrectly diagnosed due to a lack of accessible and cost-effective tools This activity will improve strategies and skills for operationalizing and utilizing biomarker data in the diagnosis of AD for diplomates involved in the care of patients with or at risk of Alzheimer’s disease.
Practice gap: Hesitancy to disclose a diagnosis of dementia This activity will assist diplomates involved in the care of patients with or at risk of Alzheimer’s disease with expertise in communicating biomarker results and guiding patients through next steps in care.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Psychiatry and Neurology
Commercial Support?
YesNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Incorporate blood biomarker testing into diagnostic workflows to facilitate an early identification of AD
Implement strategies for communicating blood biomarker test results and coordinating appropriate follow-up care to support treatment planning
Keywords
Dementia, Alzheimer's Disease, Geriatric care
Competencies
Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Outpatient, Rural, Urban
